Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
Clinical trial NCT01025453 · COMPLETED
Trial details
- NCT number
- NCT01025453
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2018-01-16
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.